ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,862Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 1448

$847K Total Retail Price of All Prescriptions

Rank: 44 out of 1448

887 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,403 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CARVEDILOL 1,774 1,504 10 1 1
FUROSEMIDE 1,346 1,197 2 7
RAMIPRIL 811 696 10 3 36
ATORVASTATIN CALCIUM 782 711 4 4
CLOPIDOGREL 575 528 5 10
SIMVASTATIN 554 511 6 3
PLAVIX 403 378 7 14
LISINOPRIL 362 265 8 5
DIOVAN 330 307 9 15
METOPROLOL SUCCINATE 319 307 10 6
AMLODIPINE BESYLATE 281 237 11 2
CRESTOR 281 248 11 17
POTASSIUM CHLORIDE 247 223 13 19
METOPROLOL TARTRATE 245 192 14 9
SPIRONOLACTONE 219 167 15 24
HYDRALAZINE HCL 198 159 16 44
EFFIENT 171 110 17 69
HYDROCHLOROTHIAZIDE 171 157 17 18
LIPITOR 161 143 19 30
LOSARTAN POTASSIUM 157 143 20 11
LOVAZA 128 114 21 39
DIGOXIN 126 126 22 13
METOLAZONE 124 103 23 124
OMEPRAZOLE 98 91 24 23
MULTAQ 88 81 25 57
NIASPAN 83 61 26 47
WARFARIN SODIUM 80 72 27 8
PRADAXA 78 77 28 27
BYSTOLIC 74 70 29 32
ZETIA 72 72 30 28
TRILIPIX 69 53 31 86
RANEXA 68 64 32 37
CILOSTAZOL 62 60 33 95
BENAZEPRIL HCL 60 48 34 26
KLOR-CON M20 53 52 35 161
ISOSORBIDE MONONITRATE ER 52 48 36 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.